Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
830.22
831.27
950.21
701.11
764.02
861.48
788.13
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
830.22
831.27
950.21
701.11
764.02
861.48
788.13
Raw Material Cost
254.28
220.37
237.14
249.47
271.61
246.73
267.18
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
3.26
3.24
5.18
3.03
2.99
3.05
22.30
Selling and Distribution Expenses
343.35
396.36
390.96
302.40
324.68
397.45
371.18
Other Expenses
15.36
11.34
23.86
8.99
10.01
11.73
13.31
Total Expenditure (Excl Depreciation)
754.45
733.35
871.92
644.78
699.37
764.52
793.76
Operating Profit (PBDIT) excl Other Income
75.8
97.89999999999999
78.3
56.3
64.7
97
-5.6000000000000005
Other Income
17.30
13.64
62.59
28.97
25.97
9.87
17.47
Operating Profit (PBDIT)
137.91
157.51
158.63
125.41
129.29
156.15
33.86
Interest
3.26
3.24
5.18
3.03
2.99
3.05
22.30
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
575.93
610.91
713.07
451.64
492.42
614.75
520.96
Depreciation
56.66
56.66
50.03
50.03
49.32
49.32
54.07
Profit Before Tax
77.99
97.61
103.42
72.36
76.99
103.79
-42.51
Tax
5.28
17.46
3.82
13.37
13.84
18.23
-59.43
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
67.88
79.28
104.29
57.27
58.96
83.41
34.72
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
67.88
79.28
104.29
57.27
58.96
83.41
34.72
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
4.84
0.88
-4.68
1.72
4.20
2.14
-17.78
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
72.72
80.16
99.61
58.99
63.16
85.55
16.94
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
4,965.66
4,897.78
4,818.51
4,714.22
4,656.95
4,597.99
4,514.58
Earnings per share (EPS)
0.12
0.14
0.18
0.1
0.1
0.15
0.06
Diluted Earnings per share
0.12
0.14
0.18
0.1
0.1
0.15
0.06
Operating Profit Margin (Excl OI)
7.7%
10.49%
4.84%
6.62%
7.07%
11.26%
-4.78%
Gross Profit Margin
16.22%
18.56%
16.15%
17.46%
16.53%
17.77%
1.47%
PAT Margin
8.18%
9.54%
10.98%
8.17%
7.72%
9.68%
4.4%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is 8.66% vs -15.19% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is 15.03% vs -48.07% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is 16.75% vs -21.27% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is 10.00% vs 0.00% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Compare Quarterly Results Of Jiangsu Kanion Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
830.22
0
830.22
Other Operating Income
0.00
0.00
0.00
Total Operating income
830.22
0
830.22
Raw Material Cost
254.28
0
254.28
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
3.26
0
3.26
Selling and Distribution Expenses
343.35
0
343.35
Other Expenses
15.36
0.00
15.36
Total Expenditure (Excl Depreciation)
754.45
0
754.45
Operating Profit (PBDIT) excl Other Income
75.77
0.00
75.77
Other Income
17.30
0
17.30
Operating Profit (PBDIT)
137.91
0
137.91
Interest
3.26
0
3.26
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
575.93
0
575.93
Depreciation
56.66
0
56.66
Profit Before Tax
77.99
0
77.99
Tax
5.28
0
5.28
Provisions and contingencies
0
0
0.00
Profit After Tax
67.88
0
67.88
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
67.88
0
67.88
Share in Profit of Associates
0
0
0.00
Minority Interest
4.84
0
4.84
Other related items
0.00
0.00
0.00
Consolidated Net Profit
72.72
0
72.72
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
4,965.66
0
4,965.66
Earnings per share (EPS)
0.12
0
0.12
Diluted Earnings per share
0.12
0
0.12
Operating Profit Margin (Excl OI)
7.70%
0%
0.00
7.70%
Gross Profit Margin
16.22%
0%
0.00
16.22%
PAT Margin
8.18%
0%
0.00
8.18%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 83.02 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -0.13% vs -12.51% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 8.66% vs -15.19% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 7.27 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -9.35% vs -19.48% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 15.03% vs -48.07% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 12.06 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -16.19% vs 49.90% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 16.75% vs -21.27% in Jun 2025
Quarterly - Interest
Interest 0.33 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 3.13% vs -38.46% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 10.00% vs 0.00% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 7.70%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Footer loading
